Related Experiment Video
Updated: Mar 24, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Role of Growth Hormone and Insulin-Like Growth Factor-1 in Modulating Disease Severity in Children with COVID-19 and
Kateryna Kozak1, Kateryna Hlushko1, Iryna Sarapuk1
1Department of Pediatrics No.2, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.
Insights
Growth hormone (GH) and insulin-like growth factor-1 (IGF-1) may influence COVID-19 and MIS-C severity in children. Lower GH and IGF-1 levels were associated with increased disease severity and risk of multisystem inflammatory syndrome in children (MIS-C).
Area of Science:
- Pediatric Endocrinology
- Infectious Diseases
- Immunology
Background:
- SARS-CoV-2 infection (COVID-19) and multisystem inflammatory syndrome in children (MIS-C) have variable clinical courses influenced by multiple factors.
- The somatotropic axis, involving growth hormone (GH) and insulin-like growth factor-1 (IGF-1), may play an immunomodulatory role in disease susceptibility and severity.
Purpose of the Study:
- To investigate the potential role of GH and IGF-1 in the clinical course of COVID-19 and MIS-C in pediatric patients.
- To explore the association between GH and IGF-1 levels and disease severity markers.
Main Methods:
- A cohort study in Ukraine (2021-2023) analyzed GH and IGF-1 levels in 90 children (1 month-17 years) with COVID-19, MIS-C, or as healthy controls.
- Hormone levels were measured using enzyme-linked immunosorbent assay (ELISA).
Main Results:
- Children with MIS-C had significantly lower GH levels than healthy controls. Reduced IGF-1 levels were more frequent in severe COVID-19 and MIS-C.
- Low GH and IGF-1 levels correlated with inflammatory markers (CRP, ferritin, IL-6) and immune cell changes (neutrophilia, lymphopenia).
- Specific GH and IGF-1 thresholds were associated with increased risk of severe COVID-19 and MIS-C.
Conclusions:
- GH and IGF-1 levels are associated with COVID-19 and MIS-C severity in children.
- The immunomodulatory roles of GH and IGF-1 should be considered in managing pediatric infectious diseases, even in previously healthy children.
Introduction:
Multiple factors have been reported to influence both the acute clinical course of SARS-CoV-2 infection (COVID-19) and the risk of developing multisystem inflammatory syndrome in children (MIS-C), including age, sex, ethnicity, comorbidities, and genetic susceptibility. However, additional immunomodulatory influences, including the somatotropic axis - comprising growth hormone (GH) and insulin-like growth factor-1 (IGF-1) - may also contribute to variations in disease susceptibility and severity. This study aimed to explore the potential role of GH and IGF-1 in the clinical course of COVID-19 and MIS-C.
Patients And Methods:
A cohort study was conducted in Ukraine from 2021 to 2023. This study analyzed GH and IGF-1 levels in 90 children aged 1 month to 17 years: 63 with COVID-19, 15 with MIS-C, and 12 healthy non-infected by SARS-CoV-2 peers. Hormone levels were measured using an enzyme-linked immunosorbent assay (ELISA).
Results:
GH levels were within the age- and sex-specific reference ranges in all children. However, children in the MIS-C group had significantly lower GH levels than those in the healthy control group. Overall, 27 (30%) patients exhibited reduced IGF-1 levels. The frequency of low IGF-1 increased with disease severity: 12.5% (mild), 25% (moderate), 53.3% (severe COVID-19), and 66.7% (MIS-C). Reduced GH levels correlated with elevated CRP and ferritin levels, neutrophilia, lymphopenia, and increased neutrophil-to-lymphocyte ratio. Low IGF-1 levels were associated with higher levels of CRP, procalcitonin, ferritin, ESR, and IL-6. A GH level <0.54 ng/mL increased the risk of severe COVID-19 by 2.05-fold (AUC = 0.656, 95% CI [0.49-0.83], p = 0.058), while a level <0.465 ng/mL was associated with MIS-C (AUC = 0.742, 95% CI [0.64-0.85], p = 0.003). An IGF-1 level <52.5 ng/mL showed a trend toward severe COVID-19 (AUC = 0.591, 95% CI [0.44-0.74], p = 0.270), whereas <44.1 ng/mL predicted MIS-C (AUC = 0.838, 95% CI [0.72-0.95], p < 0.001).
Conclusion:
Understanding how GH and IGF-1 influence the pediatric immune system is crucial for anticipating the progression of infectious diseases such as COVID-19 and MIS-C. Their immunomodulatory roles should be considered not only in children with GH deficiency but also in previously healthy patients during clinical monitoring.
Related Concept Videos
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Nature and Nurture
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

